In recent years, researchers have turned to the WNT/β-catenin signalling pathway to find alternatives aimed at reducing hyperpigmentation spots. This has allowed them to find a link between the WNT/β-catenin signalling pathway and melanogenesis.
The WNT/β-catenin signalling pathway: what are we talking about?
The Microphthalmia-associated transcription factor (MITF) acts as a primary regulator of the development, function, and survival of melanocytes by modulating various differentiation and cell cycle progression genes. It operates as a regulator of melanin synthesis by controlling the expression of tyrosinase, an enzyme that converts tyrosine into melanin. The β-catenin can directly interact with the MITF protein itself, and then activate the specific target genes of MITF.
WNT/β-catenin pathway and pigmentation spots: what does the study say?
This scientific study has highlighted the link between the WNT/β-catenin signalling pathway and the appearance of pigmented spots. Indeed, a chemical compound, cardamom, was found to inhibit the accumulation of melanin by inhibiting the WNT/β-catenin signalling pathway. To achieve this, cardamom promoted the degradation of intracellular β-catenin, thereby repressing the expression of MITF and tyrosinase. The activated WNT/β-catenin signalling pathway is thus responsible for an excessive production of melanin, which leads to hyperpigmented spots. Compounds that inhibit the WNT/β-catenin signalling pathway, such as cardamom, pave the way for new research, as they could potentially constitute interesting depigmenting agents.